Endogenous heparinoids contribute to coagulopathy in patients with liver disease

Journal of Hepatology

Volumn 48, Issue 2, 2008, Pages 371-372

  Senzolo, M ^a,b   Riddell, A ^b   Tuddenham, E ^b   Burroughs, A K ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARINOID;

BLOOD CLOTTING DISORDER; HEMOSTASIS; HEPATITIS; HUMAN; LETTER; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HEMORRHAGE; LIVER TRANSPLANTATION; MAST CELL; PRIORITY JOURNAL; THROMBOELASTOGRAPHY;

BLOOD COAGULATION DISORDERS; GLYCOSAMINOGLYCANS; HEMOSTASIS; HUMANS; LIVER DISEASES;

EID: 37849047938     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.11.003     Document Type: Letter

References (9)

1. Tripodi A., and Mannucci P.M. Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. J Hepatol 46 (2007) 727-733
2. Goulis J., Patch D., and Burroughs A.K. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 353 (1999) 139-142
3. Montalto P., Vlachogiannakos J., Cox D.J., Pastacaldi S., Patch D., and Burroughs A.K. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 37 (2002) 463-470
4. Thalheimer U., Triantos C., Samonakis D., Patch D., Burroughs A.K., Riddell A., et al. Endogenous heparinoids in acute variceal bleeding. Gut 54 (2005) 310-311
5. Zambruni A., Thalheimer U., Coppell J., Riddell A., Mancuso A., Leandro G., et al. Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients. Scand J Gastroenterol 39 (2004) 830-836
6. Senzolo M., Coppell J., Cholongitas E., Riddell A., Triantos C., Perry D., et al. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis 18 (2007) 227-236
7. Senzolo M., Cholongitas E., Riddell A., Coppel J., Thalheimer U., and Burroughs A.K. Heparinase I, II and III modified thromboelastography for the detection of different Glycosaminoglycans' effect in cirrhotics with bacterial infection. J Hepatol 44 (2006) S72
8. McKee R.F., Hodson S., Dawes J., Garden O.J., and Carter D.C. Plasma concentrations of endogenous heparinoids in portal hypertension. Gut 33 (1992) 1549-1552
9. Horne III M.K., Stein C.A., LaRocca R.V., and Myers C.E. Circulating glycosaminoglycan anticoagulants associated with suramin treatment. Blood 71 (1988) 273-279